BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,677 | +380.9% | 2,024 | +538.5% | 0.00% | – |
| Q2 2023 | $10,122 | -45.9% | 317 | -48.1% | 0.00% | – |
| Q1 2023 | $18,709 | +13.4% | 611 | +44.8% | 0.00% | – |
| Q4 2022 | $16,504 | -94.8% | 422 | -93.7% | 0.00% | -100.0% |
| Q3 2022 | $319,000 | +13.1% | 6,709 | -7.4% | 0.00% | 0.0% |
| Q2 2022 | $282,000 | -54.4% | 7,248 | -32.9% | 0.00% | 0.0% |
| Q1 2022 | $619,000 | -24.0% | 10,802 | +5.6% | 0.00% | 0.0% |
| Q4 2021 | $815,000 | -2.9% | 10,231 | +6.2% | 0.00% | -50.0% |
| Q3 2021 | $839,000 | -31.2% | 9,631 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $1,219,000 | +202.5% | 9,478 | +88.2% | 0.00% | +100.0% |
| Q1 2021 | $403,000 | +391.5% | 5,037 | +403.7% | 0.00% | – |
| Q4 2020 | $82,000 | +10.8% | 1,000 | -66.7% | 0.00% | – |
| Q3 2020 | $74,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |